United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $250.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $36.0M | 14.4% |
| Business Acquisitions | $3.5M | 1.4% |
| Other Investing | $49.9M | 20.0% |
| Stock Repurchases | $160.8M | 64.3% |
| Net Cash Flow | $0 | 0.0% |